Publication | Closed Access

Drug Repositioning for Preeclampsia Therapeutics by In Vitro Screening: Phosphodiesterase-5 Inhibitor Vardenafil Restores Endothelial Dysfunction via Induction of Placental Growth Factor

Translational MedicinePlacental Growth FactorPreeclampsia TherapeuticsVitro ScreeningMaternal Cardiovascular OutcomePharmacologyPregnancyMaternal HealthPlacental DiseaseObstetricsMaternal-fetal MedicinePublic HealthMedicinePreeclampsiaHigh-risk Pregnancy